Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 2656 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Pfizer launches new stem cell research unit

According to Pfizer, scientists at Pfizer Regenerative Medicine will explore the use of stem cells to develop future treatments that may prevent disability, repair failing organs and treat

Mortara extends ECG Warehouse CRADA with FDA

Under this extension of this cooperative R&D agreement (CRADA), Mortara will continue to provide on-going development enhancements to the electrocardiogram (ECG) Warehouse, which is used to store and

Sirius Genomics names three new board members

Previously, Dr Dreismann served as president and CEO of Roche Molecular Diagnostics, a molecular diagnostics company. Dr Fibiger was previously the vice president and global head of neuroscience

Harvard Bioscience names new CFO

Mr McNaughton most recently served as CFO for Tivoli Audio, a venture capital-backed global manufacturer of audio systems. Prior to joining Tivoli, Mr McNaughton spent 14 years at

Javelin Pharmaceuticals to reduce workforce by 15%

Martin Driscoll, CEO of Javelin Pharmaceuticals, said: “We have taken difficult, but necessary actions, to reduce fixed costs across the organization to conserve and extend valuable development dollars.

AnaSpec opens new GMP manufacturing facility

Located adjacent to its current San Jose, California-based headquarters, the expansion provides an additional 5000sqft of dedicated GMP space including two class 10,000 clean rooms. Optimized for bulk

Joshua Partners acquires Medicia

As a result of the acquisition, Medicia, now renamed Medicia Holdings, is a minority-controlled business enterprise, with official certification pending. Dale Dvorak, CEO of Medicia, said: “This is